Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
66,729,680
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
4,044,287
-
Shares change
-
+3,736,670
-
Total reported value, excl. options
-
$56,123,192
-
Value change
-
+$53,680,856
-
Put/Call ratio
-
106%
-
Number of buys
-
77
-
Number of sells
-
7
-
Price
-
$13.88
Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) as of Q1 2024
As of 31 Mar 2024 INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) had 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,044,287 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, STATE STREET CORP, GSA CAPITAL PARTNERS LLP, Qube Research & Technologies Ltd, and HRT FINANCIAL LP.
This table shows 93 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.